Sponsor:
Ionis Pharmaceuticals, Inc.
Code:
NCT07604974
Conditions
Hypertriglyceridemia
Severe Hypertriglyceridemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ION775
Brief summary:
Conditions
Hypertriglyceridemia
Severe Hypertriglyceridemia
Study ID
NCT07604974
Start date
May 12, 2026
Status verified date
Sep, 2026
Completion date
Mar, 2028
Anticipated
Primary completion date
Sep, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
72 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: ION775: Cohot A
experimental: ION775: Cohot B
experimental: ION775: Cohot C
Interventions
ION775
Primary outcome measure
Central contacts
Locations
Ionis Investigative Site
Recruiting
Lincoln, California, United States, 95648
Ionis Investigative Site
Recruiting
Aurora, Colorado, United States, 80045
Ionis Investigative Site
Recruiting
Boca Raton, Florida, United States, 33434
Ionis Investigative Site
Recruiting
Miami, Florida, United States, 33184
Ionis Investigative Site
Recruiting
Miramar, Florida, United States, 33027
Ionis Investigative Site
Recruiting
Columbus, Georgia, United States, 31904
Ionis Investigative Site
Recruiting
Carmel, Indiana, United States, 46290
Ionis Investigative Site
Recruiting
Louisville, Kentucky, United States, 40213
Ionis Investigative Site
Recruiting
Flint, Michigan, United States, 48504
Ionis Investigative Site
Recruiting
Munroe Falls, Ohio, United States, 44262
Ionis Investigative Site
Recruiting
Little River, South Carolina, United States, 29566
Ionis Investigative Site
Recruiting
Houston, Texas, United States, 77040
Ionis Investigative Site
Recruiting
Lampasas, Texas, United States, 76550
Ionis Investigative Site
Recruiting
McKinney, Texas, United States, 75071
Ionis Investigative Site
Recruiting
Mesquite, Texas, United States, 75071
Ionis Investigative Site
Recruiting
San Antonio, Texas, United States, 78209
Ionis Investigative Site
Recruiting
Québec, Canada, G1V 4W2
Sponsor
Ionis Pharmaceuticals, Inc.
Last update posted
Sep 3, 2026
Last verified
Sep, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Ionis Pharmaceuticals, Inc. on 2026-09-03.